Viral Vectors & Plasmid DNA Manufacturing Market Size to Exceed USD 23.7 Bn by 2033
24. Mai 2024 11:10 ET
|
Precedence Research
Ottawa, May 24, 2024 (GLOBE NEWSWIRE) -- The global viral vectors & plasmid DNA manufacturing market size is estimated to grow from USD 5.4 billion in 2023 to USD 20.44 billion by 2032,...
Global Viral Vector Manufacturing Market Size is Estimated to Reach USD 1790 million by 2030, Growing at a CAGR of 19.7%: Straits Research
20. Dezember 2023 09:20 ET
|
Straits Research
New York, United States, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Molecular biologists use viral vectors to introduce genetic material into cells. To treat genetic disorders, it is used to express and...
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 17.5% by 2034: Visiongain
19. Dezember 2023 12:15 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034: Forecasts by Vector Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus,...
Gene Therapy Market to hit USD 44.5 billion by 2032, says Global Market Insights Inc.
07. August 2023 17:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Gene Therapy Market size is expected to be worth USD 44.5 billion by 2032. The growing adoption of personalized medicine is generating...
Global Plasmid DNA Manufacturing Market to Surpass US$ 3,733.50 Million by 2030, Says Coherent Market Insights (CMI)
08. Februar 2023 09:00 ET
|
CMI
Burlingame, Feb. 08, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global plasmid DNA manufacturing market is estimated to be valued at US$ 735.67 million in 2022 and is expected...
Forecyte Bio's Grand Opening of the CGMP Facility in Maryland
17. Januar 2023 06:00 ET
|
Forecyte Bio
FREDERICK, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Forecyte Bio, a new global leader in cell and gene therapy contract development and manufacturing, officially opened its 17,000 square feet,...
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 18.09% by 2032: Visiongain Reports Ltd
23. Dezember 2022 06:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors and Plasmid DNA Manufacturing 2022-2032. It includes profiles of Viral Vectors and Plasmid DNA Manufacturing and Forecasts Market...
Viral Vectors and Plasmid DNA Manufacturing market is projected to grow at a CAGR of 18.09% by 2032: Visiongain Reports Ltd
27. Oktober 2022 07:51 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Viral Vectors and Plasmid DNA Manufacturing 2022-2032. It includes profiles of Viral Vectors and Plasmid DNA Manufacturing and Forecasts Market Segment...
Advent Announces Corporate Name Change to Advaxia
27. September 2022 03:00 ET
|
Advaxia
POMEZIA, Italy, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Advent announced today that it is changing its corporate name to Advaxia. The new name reflects the company's evolution, strategic growth and...
Viral Vectors and Plasmid DNA Manufacturing Market Size is projected to reach USD 9.87 Billion by 2030, growing at a CAGR of 14.71%: Straits Research
22. September 2022 12:05 ET
|
Straits Research
New York, United States, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Vectors are instruments that are used to carry genetic material into cells, and viral vectors are one such tool. Viruses have developed...